E B Keeffe

Author PubWeight™ 116.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001 2.26
2 Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997 2.16
3 Detection and surveillance of colorectal cancer. JAMA 1989 2.07
4 Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment Pharmacol Ther 2006 2.04
5 Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity. J Lab Clin Med 1979 1.86
6 Review article: hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther 2004 1.68
7 Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant 2010 1.67
8 Liver transplantation for patients with alcoholism and end-stage liver disease. Am J Gastroenterol 1993 1.64
9 Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992 1.58
10 Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review. Liver Transpl 2001 1.55
11 Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis 2001 1.54
12 Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0. Am J Gastroenterol 2000 1.53
13 Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg 1998 1.53
14 Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998 1.52
15 Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol 1999 1.50
16 A model for a managed care education approach to increase hepatitis awareness: Part I. Manag Care Interface 2000 1.39
17 Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group. Hepatology 1997 1.25
18 Current treatment strategies for chronic hepatitis B and C. Annu Rev Med 2001 1.23
19 Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant 2009 1.11
20 Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996 1.11
21 Transjugular liver biopsy. Hepatology 1992 1.11
22 Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. Ann Intern Med 1974 1.10
23 Health-related quality of life after liver transplantation: a meta-analysis. Liver Transpl Surg 1999 1.08
24 Management of biliary complications after liver transplantation. Am J Surg 1992 1.08
25 Management of gallstones and their complications. Am Fam Physician 2000 1.07
26 Re-treatment of chronic hepatitis C with consensus interferon . Hepatology 1998 1.05
27 Clinical course of hepatitis B virus infection during pregnancy. Aliment Pharmacol Ther 2009 1.04
28 Pseudomembranous enterocolitis. Resurgence related to newer antibiotic therapy. West J Med 1974 1.04
29 Pulmonary varices presenting as a solitary lung mass in a patient with end-stage liver disease. Chest 1994 1.03
30 Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 1999 1.03
31 Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides. J Viral Hepat 2009 1.01
32 Diagnosis and treatment of chronic hepatitis B: 2009 update. Minerva Gastroenterol Dietol 2009 1.00
33 Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther 2011 0.99
34 Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4. Aliment Pharmacol Ther 2008 0.98
35 Liver transplantation for treatment of giant hepatocellular adenomas. Liver Transpl Surg 1995 0.97
36 Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. J Hepatol 2001 0.97
37 Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther 2008 0.96
38 Isolated metastasis to small bowel from anaplastic thyroid carcinoma. With a review of extra-abdominal malignancies that spread to the bowel. J Clin Gastroenterol 1987 0.96
39 Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Ann Intern Med 1986 0.94
40 Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia. Am J Gastroenterol 1998 0.94
41 Esophageal burn and the microwave oven. Ann Intern Med 1982 0.94
42 Pancreatic insufficiency associated with ulcerative colitis and pericholangitis. Gastroenterology 1982 0.94
43 Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. Arch Surg 1996 0.93
44 Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Aliment Pharmacol Ther 2004 0.93
45 Liver transplantation--challenges for the future. West J Med 1991 0.92
46 Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med 1993 0.92
47 Disulfiram hypersensitivity hepatitis. JAMA 1974 0.91
48 Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl 2001 0.91
49 Gastrointestinal symptoms of marathon runners. West J Med 1984 0.90
50 Screening flexible sigmoidoscopy by primary care physicians. Effectiveness and costs in patients negative for fecal occult blood. West J Med 1986 0.90
51 Clinical approach to viral hepatitis in homosexual men. Med Clin North Am 1986 0.90
52 Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation 1994 0.90
53 Diabetic gastroparesis. Dig Dis 1996 0.89
54 Liver transplantation in Asian patients with chronic hepatitis B. Hepatology 1997 0.89
55 Hepatitis G virus: is it a hepatitis virus? West J Med 1997 0.88
56 A novel technique for endoscopic removal of expandable biliary Wallstent. Gastrointest Endosc 1999 0.88
57 An appraisal of patients' reactions to "informed consent" for peroral endoscopy. Gastrointest Endosc 1977 0.88
58 Acute pancreatitis associated with acute hepatitis A. Am J Gastroenterol 1992 0.87
59 Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. Am J Gastroenterol 2001 0.87
60 Liver transplantation: evolving patient selection criteria. Can J Gastroenterol 2001 0.87
61 Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation. Arch Surg 1994 0.87
62 Cost-effective evaluation of acute viral hepatitis. West J Med 2000 0.86
63 Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection. Am J Gastroenterol 1999 0.86
64 Isolation of a rat liver plasma membrane fraction of probable canalicular origin. Preparative technique, enzymatic profile, composition, and solute transport. Biochim Biophys Acta 1981 0.86
65 Treatment strategies for chronic hepatitis C: update since the 1997 National Institutes of Health Consensus Development Conference. J Gastroenterol Hepatol 1999 0.86
66 Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate. Dig Dis Sci 1982 0.86
67 Clinical outcome after percutaneous transhepatic obliteration of esophageal varices. Gastroenterology 1983 0.86
68 Primary sclerosing cholangitis and Hodgkin's disease. Hepatology 1993 0.86
69 Hepatitis B vaccination of patients with chronic liver disease. Liver Transpl Surg 1998 0.85
70 Alteration of rat liver plasma membrane fluidity and ATPase activity by chlorpromazine hydrochloride and its metabolites. Gastroenterology 1980 0.85
71 Long-term follow-up after liver transplantation in patients with hepatic iron overload. Liver Transpl Surg 1999 0.84
72 Diagnosis and treatment of primary biliary cirrhosis. Med Sci Monit 2001 0.84
73 Risk assessment for hepatocellular carcinoma in chronic hepatitis B: scores and surveillance. Int J Clin Pract 2012 0.84
74 Acute appendicitis secondary to metastatic cholangiocarcinoma. Am J Gastroenterol 1993 0.84
75 Prolonged cholestasis due to trimethoprim sulfamethoxazole. Gastroenterology 1992 0.84
76 Impact of transjugular intrahepatic portosystemic shunt on orthotopic liver transplantation. World J Surg 1995 0.83
77 Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients. Hepatology 2001 0.83
78 Endoscopic gastrointestinal manifestations of liver disease. Gastrointest Endosc Clin N Am 2001 0.83
79 Initial two-year results of the Oregon Liver Transplantation Program. Am J Surg 1991 0.83
80 Helicobacter pylori infection and blood group antigens: lack of clinical association. Am J Gastroenterol 1996 0.83
81 Liver transplantation for alcoholic liver disease: selection and outcome. Clin Liver Dis 1997 0.83
82 Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg 1995 0.82
83 Outcome of liver transplantation in patients with hemochromatosis. Hepatology 1994 0.82
84 Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. Dig Dis Sci 1994 0.81
85 Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? J Gastroenterol Hepatol 1999 0.81
86 Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance. Int J STD AIDS 2008 0.81
87 Primary liver transplantation without transfusion of red blood cells. Surgery 1996 0.81
88 In vitro effect of bile salts on rat liver plasma membrane, lipid fluidity, and ATPase activity. Hepatology 1981 0.81
89 Colonoscopy preps: what's best? Gastrointest Endosc 1996 0.81
90 Severe and prolonged oral contraceptive jaundice. J Clin Gastroenterol 1984 0.81
91 Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression. J Hepatol 1995 0.80
92 Hepatitis C virus and liver transplantation. Clin Liver Dis 2001 0.80
93 Sedation and analgesia for endoscopy. Gastroenterology 1995 0.80
94 Hepatotoxicity of transplant immunosuppressive agents. Gastroenterol Clin North Am 1995 0.79
95 Aortoduodenal fistula: complication of renal artery bypass graft. Gastroenterology 1974 0.79
96 Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. J Viral Hepat 2011 0.79
97 Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group. Am J Gastroenterol 1999 0.79
98 Liver biopsy in chronic hepatitis C: routine or selective. Am J Gastroenterol 2001 0.79
99 Aortic valve endocarditis after orthotopic liver transplantation. Transplantation 1994 0.78
100 Patterns of hepatitis C viremia in patients receiving hemodialysis. Am J Gastroenterol 1997 0.78
101 Trichobezoar associated with gastric polyposis. West J Med 1988 0.78
102 Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. Aliment Pharmacol Ther 2007 0.78
103 Management of variceal hemorrhage in the potential liver transplant candidate. Am J Surg 1989 0.78
104 Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting. Dig Dis Sci 1987 0.78
105 Ileal volvulus following colonoscopy. Gastrointest Endosc 1985 0.78
106 Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C. Aliment Pharmacol Ther 2003 0.78
107 Quality of life and employment after liver transplantation. Liver Transpl 2001 0.77
108 Hematologic manifestations of gastrointestinal disease. Hematol Oncol Clin North Am 1987 0.77
109 Psychological assessment of quality of life following liver transplantation. J Clin Psychol Med Settings 1994 0.77
110 The immunopathology of primary biliary cirrhosis: thoughts for the millennium. Arch Immunol Ther Exp (Warsz) 2000 0.77
111 New approaches to supporting the failing liver. Annu Rev Med 1998 0.77
112 Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group. J Viral Hepat 1998 0.76
113 Primary biliary cirrhosis: lessons learned from an organ-specific disease. Clin Exp Med 2001 0.76
114 Resection versus transplantation for hepatocellular carcinoma. J Gastroenterol Hepatol 1999 0.76
115 Diagnosis and treatment of chronic hepatitis B. Minerva Gastroenterol Dietol 2004 0.76
116 Therapy for collagenous colitis. Ann Intern Med 1987 0.76
117 Training in endoscopic procedures. J Pediatr Gastroenterol Nutr 1997 0.75
118 Hepatitis G virus: clinical relevance and responsiveness to interferon. Am J Gastroenterol 1997 0.75
119 Liver transplantation in patients with hepatic iron overload: favorable or unfavorable outcome? Hepatology 2000 0.75
120 Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma. Dig Dis Sci 1984 0.75
121 Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy. Dig Dis Sci 1986 0.75
122 Diabetes and the hepatobiliary system. Clin Liver Dis 1998 0.75
123 Diagnosis and treatment of chronic hepatitis B: an update. Minerva Gastroenterol Dietol 2007 0.75
124 Colonic lymphoma in the transplant patient. Dig Dis Sci 1989 0.75
125 Primary sclerosing cholangitis in ulcerative colitis. Ann Intern Med 1985 0.75
126 Diagnosis of sclerosing cholangitis with technetium 99m-labeled iminodiacetic acid planar and single photon emission computed tomographic scintigraphy. Gastroenterology 1987 0.75
127 Patient selection criteria for liver transplantation. Minerva Chir 2003 0.75
128 Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion. Hosp Formul 1991 0.75
129 Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay. Viral Immunol 1993 0.75
130 Ruptured abdominal aortic aneurysm causing obstructive jaundice. Dig Dis Sci 1983 0.75
131 Gastroenterology in the 21st century--strength in unity: 1996 presidential address. Gastrointest Endosc 1996 0.75
132 Liver transplantation for uncontrollable variceal bleeding. Am J Gastroenterol 1994 0.75
133 The successful use of telemedicine in acute variceal hemorrhage. J Clin Gastroenterol 1999 0.75
134 Scintigraphic criteria for the diagnosis of obstructive hepatobiliary diseases with Tc-99m IDA. Clin Nucl Med 1988 0.75
135 Determinants of safe endoscopy. Gastrointest Endosc 1994 0.75
136 Sclerotherapy versus banding in the treatment of variceal bleeding. Clin Liver Dis 1997 0.75
137 Advances in liver disease. Highlights from the 51st Annual Meeting of the American Association for the Study of Liver Diseases, October 27-31, 2000, Dallas, TX. Rev Gastroenterol Disord 2001 0.75
138 Peanut shell colitis. Arch Intern Med 1985 0.75
139 Liver transplantation at Stanford University Medical Center. Clin Transpl 1998 0.75
140 Differential diagnosis of gallstone-induced complications. South Med J 2000 0.75
141 NAFLD and NASH: important diseases before and after liver transplantation. Hepatology 2001 0.75
142 Role of emerging technology in the era of cost containment. Gastrointest Endosc Clin N Am 1997 0.75
143 Prednisone withdrawal advocates: beware of recurrent autoimmune hepatitis. Hepatology 1999 0.75
144 Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis. Transplant Proc 2001 0.75
145 A model for a managed care education approach to increase hepatitis awareness: Part. II. Manag Care Interface 2000 0.75
146 Comparative effects of blood, colloid, and Ringer's lactate terminal allograft rinse on the results of orthotopic liver transplantation. Transplant Proc 1993 0.75
147 Adenomatous polyp arising in Barrett's esophagus. J Clin Gastroenterol 1986 0.75
148 Liver transplantation at California Pacific Medical Center, San Francisco, California. Clin Transpl 1994 0.75
149 Risk of tuberculosis in tuberculin skin test-positive liver transplant patients. Clin Infect Dis 1999 0.75
150 Liver cysts associated with polycystic kidney disease: role of Tc-99m hepatobiliary imaging. Clin Nucl Med 1989 0.75
151 Overview of interferon therapy for chronic hepatitis C. Clin Liver Dis 1999 0.75
152 Outcomes and effectiveness research: the 1992 investigator conference of the American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 1994 0.75